tiprankstipranks
Valion Bio (VBIO)
NASDAQ:VBIO
US Market
VBIO
Valion Bio
RESEARCH TOOLSreports
Want to see VBIO full AI Analyst Report?

Valion Bio (VBIO) Financial Statements

166 Followers

Valion Bio Financial Overview

Valion Bio's market cap is currently $1.92M. The company's EPS TTM is $-0.03; its P/E ratio is 3.03; Valion Bio is scheduled to report earnings on May 14, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 22Mar 20Mar 19Mar 18Mar 17
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 102.42K$ 163.36K
Gross Profit$ 0.00$ 0.00$ 0.00$ 24.48K$ 55.10K
Operating Income$ -2.34M$ -3.69M$ -4.57M$ -4.40M$ -3.47M
EBITDA$ -880.85K$ -4.37M$ -4.43M$ -4.31M$ -5.22M
Net Income$ -880.85K$ -4.37M$ -20.14M$ -4.31M$ -5.22M
Balance Sheet
Cash & Short-Term Investments$ 884.14K$ 2.39M$ 5.98M$ 656.29K$ 1.15M
Total Assets$ 896.83K$ 2.57M$ 6.08M$ 675.79K$ 1.18M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -884.14K$ -2.39M$ -5.98M$ -656.29K$ -1.15M
Total Liabilities$ 33.44K$ 1.28M$ 1.05M$ 353.52K$ 800.65K
Stockholders' Equity$ 863.39K$ 1.28M$ 5.02M$ 322.27K$ 374.37K
Cash Flow
Free Cash Flow$ -1.61M$ -3.59M$ -3.67M$ -2.89M$ -1.38M
Operating Cash Flow$ -1.61M$ -3.59M$ -3.67M$ -2.89M$ -1.38M
Investing Cash Flow$ 0.00$ 0.00$ 141.54K$ 0.00$ 0.00
Financing Cash Flow$ 96.99K$ 0.00$ 8.85M$ 2.39M$ 2.44M
Currency in USD

Valion Bio Earnings and Revenue History

Income Statement >

Valion Bio Debt to Assets

Balance Sheet >

Valion Bio Cash Flow

Cash Flow >

Valion Bio Forecast EPS vs Actual EPS

Earnings >